These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37947643)

  • 1. Treating Parkinson's Disease with Human Bone Marrow Mesenchymal Stem Cell Secretome: A Translational Investigation Using Human Brain Organoids and Different Routes of In Vivo Administration.
    Mendes-Pinheiro B; Campos J; Marote A; Soares-Cunha C; Nickels SL; Monzel AS; Cibrão JR; Loureiro-Campos E; Serra SC; Barata-Antunes S; Duarte-Silva S; Pinto L; Schwamborn JC; Salgado AJ
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.
    Chierchia A; Chirico N; Boeri L; Raimondi I; Riva GA; Raimondi MT; Tunesi M; Giordano C; Forloni G; Albani D
    Eur J Pharm Biopharm; 2017 Dec; 121():113-120. PubMed ID: 28965958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of bone marrow-derived mesenchymal stem cell secretome in 6-OHDA-induced Parkinson's disease.
    Mahendru D; Jain A; Bansal S; Malik D; Dhir N; Sharma AR; Sarma P; Prakash A; Nahar U; Bhatia A; Bhattacharyya S; Medhi B
    Regen Med; 2021 Oct; 16(10):915-930. PubMed ID: 34553608
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.
    Teixeira FG; Carvalho MM; Panchalingam KM; Rodrigues AJ; Mendes-Pinheiro B; Anjo S; Manadas B; Behie LA; Sousa N; Salgado AJ
    Stem Cells Transl Med; 2017 Feb; 6(2):634-646. PubMed ID: 28191785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease.
    Marques CR; Pereira-Sousa J; Teixeira FG; Sousa RA; Teixeira-Castro A; Salgado AJ
    Cytotherapy; 2021 Oct; 23(10):894-901. PubMed ID: 34059421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionating stem cells secretome for Parkinson's disease modeling: Is it the whole better than the sum of its parts?
    Vilaça-Faria H; Marote A; Lages I; Ribeiro C; Mendes-Pinheiro B; Domingues AV; Campos J; Lanceros-Mendez S; Salgado AJ; Teixeira FG
    Biochimie; 2021 Oct; 189():87-98. PubMed ID: 34182001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model.
    Mendes-Pinheiro B; Anjo SI; Manadas B; Da Silva JD; Marote A; Behie LA; Teixeira FG; Salgado AJ
    Front Bioeng Biotechnol; 2019; 7():294. PubMed ID: 31737616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
    d'Angelo M; Cimini A; Castelli V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.
    Forouzandeh M; Bigdeli MR; Mostafavi H; Nadri S; Eskandari M
    Exp Mol Pathol; 2021 Dec; 123():104703. PubMed ID: 34619140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical potential and current progress of mesenchymal stem cells for Parkinson's disease: a systematic review.
    Chen Y; Shen J; Ke K; Gu X
    Neurol Sci; 2020 May; 41(5):1051-1061. PubMed ID: 31919699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells.
    Capitelli CS; Lopes CS; Alves AC; Barbiero J; Oliveira LF; da Silva VJ; Vital MA
    Int J Med Sci; 2014; 11(10):1049-64. PubMed ID: 25136260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.
    Mendes-Pinheiro B; Teixeira FG; Anjo SI; Manadas B; Behie LA; Salgado AJ
    Stem Cells Transl Med; 2018 Nov; 7(11):829-838. PubMed ID: 30238668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric analysis of the in vitro secretome from equine bone marrow-derived mesenchymal stromal cells to assess the effect of chondrogenic differentiation on response to interleukin-1β treatment.
    Bundgaard L; Stensballe A; Elbæk KJ; Berg LC
    Stem Cell Res Ther; 2020 May; 11(1):187. PubMed ID: 32434555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Aging Secretes: a Comparison of Bone-Marrow-Derived and Induced Mesenchymal Stem Cells and Their Secretome Over Long-Term Culture.
    Marote A; Santos D; Mendes-Pinheiro B; Serre-Miranda C; Anjo SI; Vieira J; Ferreira-Antunes F; Correia JS; Borges-Pereira C; Pinho AG; Campos J; Manadas B; Teixeira MR; Correia-Neves M; Pinto L; Costa PM; Roybon L; Salgado AJ
    Stem Cell Rev Rep; 2023 Jan; 19(1):248-263. PubMed ID: 36152233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson's disease.
    Jiaming M; Niu C
    Neurol Sci; 2015 Feb; 36(2):281-7. PubMed ID: 25159816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell secretome based approaches in Parkinson's disease regenerative medicine.
    Marques CR; Marote A; Mendes-Pinheiro B; Teixeira FG; Salgado AJ
    Expert Opin Biol Ther; 2018 Dec; 18(12):1235-1245. PubMed ID: 30422014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.